Commercialization: Page
-
PharmaVoice Team/PharmaVoice
What's New
GSW Opens New York Office New location solidifies inChord’s presence in the Northeast pharmaceutical corridor and facilitates interaction between other East Coast corporate entities. Gerbig, Snell/Weisheimer (GSW) has recently expanded its operations by opening an office in New York. The new offi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Outsourcing: A Vital Clinical Strategy
Outsourcing: A Vital Clinical Strategy A large, unmet need exists for improved research and development productivity within pharmaceutical and biotechnology companies. Outsourcing discovery research, clinical trials, and formulation manufacturing ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
DTC: The Next Phase
In light of FDA guidances, more public scrutiny, and trending corporate citizenship, DTC advertising is subtly shifting to direct-to-education. Direct-to-consumer advertising has been mainly focused on creating brand awareness for major blockbuster products, or creating awareness for new therapeu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Ideology Vs. Science: The Stem-Cell Battle
Ideology Vs. Science: The Stem-Cell Battle By Kim Ribbink Across the globe, scientists are extolling the potential of stem- cell research to cure debilitating diseases, in spite of limits on federal funding as well as controversy surrounding the research. States and private investors have begun t...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Colin J. Foster In the Aftermath of September 11, U.S. Security is A New Reason to Improve Science Education Innovations in science and technology have long been synonymous with economic prosperity. On the other hand, it’s probably safe to say that science and technology and the st...
By Colin J. Foster • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Risk Aversion As a Profitability-Limiting Factor in Clinical-Trial Conduct
Risk Aversion As a Profitability-Limiting Factor in Clinical-Trial Conduct What is risk? Why does it matter? Shouldn’t prudent business people try to avoid it? How does it impact the conduct of clinical trials, and can it or should it change? Timothy Pratt, Ph.D., Chief marketing officer of MedNe...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
CME Programs Accredited by Universities and Societies Receive Preference Continuing medical education (CME) programs created by medical communications agencies achieve a higher level of acceptance among physicians when they are accredited through partnerships with respected university medical sch...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Taren Grom Companies are striving to improve competence in the key sales drivers — targeting, frequency, message, and coaching. May the force be with you… Anyone who has been to the doctor’s office in the past few years no doubt has noted that the waiting room, which was once occupied by...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Sales Training
The Sales Process Plan Pre-Sale Sale Grow Building Relationships Grow Usage Customer Relationship Management Referral Systems Target Thought Leaders Territory Management Sales Call Product Knowledge Presentation Customer Service Value-Added Programs Support Support District Manager ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Kevin Guthrie Thom Rowland Solvay Promotes VPs Solvay Pharmaceuticals, Marietta, Ga., a pharmaceutical company focused on cardiology, gastroenterology, mental health, women’s health, and select specialized markets, has promoted Kevin Guthrie to VP of commercial operations, neuroscienc...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Biotech's Perfect Storm
Biotech’s Perfect Storm A relatively more favorable funding environment, cutting-edge technologies, and a strong position at the partnership table have many of today’s biotechnology companies poised for success. Biotechnology companies have come into their own. A report from Ernst & Young fi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Time for Transparency
June 2005 PharmaVOICE Trial transparency The Time for Transparency by Elisabeth Pena Villarroel The movement toward clinical-trial transparency and public registries is not a new idea, however, the highly publicized lawsuit by Eliot Spitzer against GlaxoSmithKline and the terms of the settlement ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Learning Gets Personal
David Werboff Group Director, Project Management Informa Training Partners Ron Burns President protonMEDIA There will always be a time and a place for text-based training programs as well as face-to-face, in-person workshops, but today’s e-learning programs are filling in...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Applying Instructional Design: Creating Training So Adults Get It, Retain It, and Use It
Applying Instructional Design: Creating Training So Adults Get It, Retain It, and Use It Debra L. Newton President Constance Billé, M.Ed. Instructional Strategist Lifelong learning has become both an absolute necessity and a fact of life. From manufacturing to service providers, work...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Seven Elements of an Effective Compliance Program: Don't Miss the Train
The federal and state governments have the pharmaceutical industry in their enforcement crosshairs. Multihundred million dollar settlements are no longer uncommon. As a result of these high-media-profile activities, large and small pharmaceutical companies are paying closer attention to the activ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Letter from the Editor The Forum Sales Training: Strategic Initiatives to Improve Sales Effectiveness: Top-Level Commitment, Cooperation, Performance Measurement, and Front-Line Management Company Listing by Topic of Interest Compliance Training HCPro Inc. — Seven Elements of an Effective Complia...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Sales Leadership Training for the Shifting Role of District Managers
George Schmidt Practice Executive Sales Practice Today’s district managers (DMs) operate in a very difficult environment. Sales reps face stiff competition in the field, physician access continues to decrease, the selling environment is more complex, and reps require more coaching and guida...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Simplify, Focus, and Align the Sales Process: New Performance Drivers for Success
Complexity and information overload are making it harder than ever for salespeople to execute brand strategy. The way sales reps communicate with physicians is woefully out of sync with the way physicians learn and incorporate new therapies...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
May 16-17 Global Clinical Trials Hyatt Regency Jersey City, Jersey City, N.J. For more information, contact Caria Badenhorst, Marcus Evans, at 246-417-5321, e-mail [email protected], or visit marcusevans.com. May 16-17 5th Annual Sample Accountability Hyatt Regency Princeton, Princeton, N....
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
PharmaVOICE June 2005 Letter from the Editor In 1990, some very smart women realized that to effect change in the industry, HBA was going to have to take an active role in recognizing women in leadership positions and increasing their visibility in the industry. “Since then, we have been recogniz...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
What’s on Your Mind — Opinions Opinions Blogs, which often combine a mixture of what is happening in a person’s life and what is happening on the Web into a type of hybrid diary/guide site, are quickly becoming important online resources for consumers and patients. Bloggers share personal informa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
It's All About Changing Practice
It’s All About Changing Practice Each and every step along the drug-development path must focus on the end game — to define the place of a new drug in practice, and then to communicate the data clearly and consistently using all available channels. But can companies make themselves heard in th...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Creating a Guidance System for Life-Science Brands
Creating a Guidance System for Life-Science Brands While meaningful biomedical research depends on proteomics, genetics, and genomics tools, their ultimate application also will depend on successful commercialization and marketing tools. Mark Stinson President ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Personalized Medicine: Our Industry's Next Great Leap Forward
Personalized Medicine: Our Industry’s Next Great Leap Forward Marketing Personalized medicine will drive medicine to become much more of a science than an art. And with that change, there will be many necessary fundamental changes to how our industry markets these innovations. Ri...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Marketing Strategies for Emerging Companies: Lessons from the Maine Wilderness
Marketing Strategies for Emerging Companies: Lessons from the Maine Wilderness for Biotech and Biopharma I do not consider a sale complete until the goods are worn out and the customer (sic) is still satisfied.” When Leon Leonwood Bean posted those words in his humble Maine store in 1916 he wa...
By PharmaVoice Team • Jan. 2, 2008
Previous
